Literature DB >> 1385254

Serum and liver hepatitis B virus DNA in chronic hepatitis B after sustained loss of surface antigen.

M Kuhns1, A McNamara, A Mason, C Campbell, R Perrillo.   

Abstract

Polymerase chain reaction (PCR) was used to detect hepatitis B virus DNA in the sera and livers of nine patients with chronic hepatitis B after treatment-induced or spontaneous loss of serum hepatitis B surface antigen. Patients were evaluated at intervals ranging from 3 to 67 months after disappearance of hepatitis B surface antigen. PCR was performed using primer pairs from the surface and core gene regions, and surface gene products were quantitated. Liver tissue was also evaluated by in situ hybridization to assess viral transcription. Five of the nine patients had viral DNA detectable in serum by PCR. Quantitation of polymerase chain reaction products in serum and liver showed that the DNA levels tended to decline progressively after antiviral therapy. Six of seven surface antigen-negative patients tested had detectable viral DNA in the liver, and four of the six DNA-positive patients were negative for DNA in serum by PCR. None had surface gene messenger RNA. Thus, it is concluded that hepatitis B virus DNA may be detectable by PCR in liver tissue years after the disappearance of hepatitis B surface antigen, even in the absence of detectable hepatitis B virus DNA in serum.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1385254     DOI: 10.1016/0016-5085(92)91191-6

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  15 in total

Review 1.  Diagnosis and management of clinical and subclinical cobalamin deficiency: advances and controversies.

Authors:  Ralph Carmel; Mona Sarrai
Journal:  Curr Hematol Rep       Date:  2006-03

2.  Previous or occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma without hepatic fibrosis.

Authors:  S Kubo; A Tamori; K Ohba; T Shuto; T Yamamoto; H Tanaka; S Nishiguchi; K Wakasa; K Hirohashi; H Kinoshita
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

3.  Spontaneous hepatitis B surface antigen clearance in a long-term follow-up study of patients with chronic type B hepatitis. Lack of correlation with hepatitis C and D virus superinfection.

Authors:  L C Da Silva; C L Madruga; F J Carrilho; J R Pinho; A Saéz-Alquezar; C Santos; L Bassit; C Barreto; L E Fonseca; V A Alves; R Leitão; R Vianna; R A Cardoso; A V França; L C Gayotto
Journal:  J Gastroenterol       Date:  1996-10       Impact factor: 7.527

Review 4.  Interferon in the management of chronic hepatitis B.

Authors:  R P Perrillo
Journal:  Dig Dis Sci       Date:  1993-04       Impact factor: 3.199

Review 5.  Risks and benefits of interferon-alpha in the treatment of hepatitis.

Authors:  M Pardo; E Marriott; M C Moliner; J A Quiroga; V Carreño
Journal:  Drug Saf       Date:  1995-11       Impact factor: 5.606

6.  Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B.

Authors:  Teerha Piratvisuth; George Lau; You-Chen Chao; Rui Jin; Anuchit Chutaputti; Q-B Zhang; Tawesak Tanwandee; Peter Button; Matei Popescu
Journal:  Hepatol Int       Date:  2008-02-05       Impact factor: 6.047

7.  High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan.

Authors:  H Marusawa; Y Osaki; T Kimura; K Ito; Y Yamashita; T Eguchi; M Kudo; Y Yamamoto; H Kojima; H Seno; F Moriyasu; T Chiba
Journal:  Gut       Date:  1999-08       Impact factor: 23.059

8.  Evaluation of liver tissue by polymerase chain reaction for hepatitis B virus in patients with negative viremia.

Authors:  Fouad Thakeb; Magdy El-Serafy; Soheir Zakaria; Bahaa Monir; Sahar Lashin; Raghda Marzaban; Mostafa El-Awady
Journal:  World J Gastroenterol       Date:  2005-11-21       Impact factor: 5.742

9.  Interferon for hepatitis B: US experience.

Authors:  R P Perrillo
Journal:  Gut       Date:  1993       Impact factor: 23.059

10.  Hepatitis B virus persistence after recovery from acute viral hepatitis.

Authors:  T I Michalak; C Pasquinelli; S Guilhot; F V Chisari
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.